Our Approach to Cataract & Lens Disorders
Montefiore Einstein is an internationally recognized leader, providing comprehensive, state-of-the-art care for adults and children with the full spectrum of cataract and lens disorders, from age-related, secondary, and traumatic cataract to congenital and pediatric cataract, complex lens dislocations, and rare lens anomalies. Our multidisciplinary team of world-renowned doctors includes board certified ophthalmologists with advanced expertise in cataract and lens surgery who collaborate closely with optometrists, retina, glaucoma, pediatric and oculoplastics specialists, primary care physicians and other providers to ensure seamless, coordinated care. Our cataract specialists are experts in the most advanced treatments, offering the latest diagnostics and lens-based solutions. These treatments range from monofocal and toric (astigmatism-correcting) intraocular lenses (IOLs) to multifocal lenses, advanced presbyopia-correcting options such as extended depth-of-focus (EDOF) lenses that allow for postoperative vision customization. We use state-of-the-art phacoemulsification platforms, micro- and small-incision techniques and high-definition three-dimensional (3D) visualization systems to enhance surgical precision and promote faster recovery. As a referral center, we specialize in both routine and the most complex cataract cases, including those requiring advanced techniques for lens dislocation, traumatic cataract or coexisting ocular conditions such as glaucoma, corneal disease or prior refractive surgery.
We provide an individualized approach to cataract care, tailoring each treatment plan to the patient’s unique ocular anatomy, vision goals and lifestyle. Our specialists prioritize shared decision-making to ensure each patient is informed and empowered throughout their care. As pioneers in cataract and minimally invasive eye surgery, our physician-scientists also co-invented the Trabectome, the first U.S. Food and Drug Administration (FDA)-cleared device for minimally invasive glaucoma surgery (MIGS), which is often performed in combination with cataract surgery to help lower intraocular pressure in individuals with coexisting glaucoma. For individuals with congenital cataract or syndromic conditions with lens involvement, we offer genetic counseling and work together with the Children’s Hospital at Montefiore Einstein’s Pediatric Genetic Medicine, one of the nation’s first and most renowned programs. For more than 50 years, we have been leading the way in genetic and genomic disease care and continue to serve as a model for the field.
Internationally Recognized Care, Close to Home
Our state-of-the-art Lasik and Eye Care Center expands access to world-renowned vision care for patients across New York State. Designed to enhance the patient experience, the Center features customized operating suites equipped with the most advanced cataract surgical technologies available including the latest phacoemulsification platforms, and high-definition operating microscopes. Nearly all procedures are performed on an outpatient basis, enabling patients to receive leading-edge care in a comfortable, accessible setting close to home.
Diagnóstico y tratamientos avanzados
We offer the most advanced diagnostics and treatments for the prevention, detection and management of all types and stages of cataract and lens disorders. Montefiore Einstein’s state-of-the-art diagnostic technologies deliver exceptional precision in cataract evaluation and treatment planning. We utilize advanced swept-source optical coherence tomography (OCT) biometry, high-resolution corneal topography and tomography, posterior corneal astigmatism analysis.
Montefiore Einstein offers a wide range of nonsurgical management strategies for individuals who are not yet candidates for surgery, including prescription optimization, glare reduction and lifestyle modifications, along with advanced imaging to monitor cataract progression over time providing seamless, patient-centered care at every stage.
To ensure comprehensive care, we perform thorough preoperative assessments of the macula and optic nerve, allowing us to optimize outcomes for patients with coexisting retinal conditions. For families affected by congenital cataract, our Program collaborates with the world-renowned Division of Genetics at the Children’s Hospital at Montefiore Einstein (CHAM) to integrate advanced genetic testing including massively parallel next-generation sequencing—with compassionate genetic counseling. This comprehensive approach empowers adults and children and their families to make fully informed decisions about their care while understanding the genetic factors that may influence treatment options.
When surgery is the best option for restoring your vision, we offer a full range of the most advanced cataract removal and lens replacement procedures available today. Our world-renowned Montefiore Einstein cataract surgeons employ leading-edge techniques designed to deliver exceptional outcomes with maximum comfort and precision. Our surgical options include microincision phacoemulsification with intelligent fluidics for gentle, efficient cataract removal. For complex cases requiring specialized care, we use advanced micro- and small-incision approaches tailored to each patient’s unique needs.
Our AI-enhanced surgical planning tools analyze comprehensive biometric data to support highly accurate IOL power prediction, refine toric lens alignment and anticipate the best possible postoperative visual outcomes. During surgery, digital guidance systems seamlessly overlay preoperative planning data onto the surgical field, enhancing incision placement precision and toric IOL alignment accuracy.
Montefiore Einstein provides the latest premium IOL technologies to achieve customized vision correction for adults and children. Our extensive lens portfolio includes monofocal, and toric (astigmatism-correcting), multifocal. Each lens option is carefully selected to match your specific vision goals and lifestyle needs.
Our cataract surgeons are experts in managing the most challenging eye and lens conditions, including lens subluxation or dislocation, zonular weakness, previous refractive surgery complications and coexisting glaucoma. We employ sophisticated techniques such as scleral- or iris-fixated IOLs, capsular tension devices and combined MIGS to achieve optimal outcomes even in the most complex situations.
Montefiore Einstein extends beyond surgery to include advanced preoperative optimization and personalized postoperative care. We manage ocular surface conditions, such as dry eye and meibomian gland dysfunction (MGD), prior to surgery to ensure the highest level of biometric accuracy and enhance surgical outcomes.
For appropriate candidates, we offer dropless cataract surgery, reducing the need for postoperative eye drops through intracameral medication delivery during the procedure. Postoperatively, we provide individualized rehabilitation plans that may include secondary enhancements and yttrium aluminum garnet (YAG) laser capsulotomy for posterior capsular opacification when necessary, to ensure optimal vision restoration.
Montefiore Einstein’s comprehensive suite of advanced diagnostics and treatments for cataract and lens disorders includes:
Ophthalmology Research
Montefiore Einstein is leading collaborative research and spearheading numerous studies and clinical trials, including several funded by the National Eye Institute (NEI)/National Institutes of Health (NIH), translating novel scientific discoveries into new diagnostics and treatments to help improve clinical outcomes. Through our clinical trials, our patients can access emerging technologies and innovative treatments that may otherwise be unavailable to the general public.
Our research spans basic, translational and clinical science, with a focus on advancing the diagnosis, treatment and long-term management of cataract and complex lens-related conditions. Key areas of investigation include the development of novel surgical techniques and technologies, next-generation IOL solutions and data-driven strategies to improve surgical outcomes. We are studying the use of AI to help improve the performance of IOL calculation formulas and provide an enhanced framework for IOL formula optimization.
Beyond surgical innovation, our research addresses critical challenges in perioperative care, medical therapy and surgical education. We are evaluating the role of perioperative pharmacologic strategies in cataract surgery, including the use of NSAIDs to reduce perioperative inflammation, drug-eluting intraocular implants for sustained antimicrobial protection and systemic medications that influence iris physiology, such as alpha-adrenergic antagonists, and their effects on surgical outcomes. We are also exploring nonsurgical therapeutic approaches, including a subgroup analysis from a Phase 1/2 randomized clinical trial evaluating 2.6% edetate disodium (EDTA) ophthalmic solution as a potential medical treatment for patients with age-related cataract.
Our team is also leading efforts to advance surgical training and education through the use of high-fidelity simulators, with a focus on the evaluation of ophthalmic surgical simulators for continuous curvilinear capsulorhexis training and the impact of case complexity in resident-performed cataract surgery.
Trusted Global Leaders in Evidence-Based Eye Care
Montefiore Einstein is one of only 13 centers worldwide designated as a Cochrane Eyes and Vision (CEV) Center for Evidence-Based Vision Care, a prestigious NEI/NIH-funded distinction. This recognition reflects our world-renowned commitment to advancing evidence-based medicine and establishing the most effective treatments in patient care. Our research contributions serve as a global model for clinical sites worldwide.
Our Cataract & Lens Disorders Team
Richard P. Gibralter, MD
Our multidisciplinary team of world-renowned ophthalmologists specializes in the diagnosis and management of the full spectrum of cataract and lens disorders, using the most advanced medical and surgical techniques to preserve, restore and enhance vision, prevent further vision loss, reduce dependence on glasses and improve quality of life for each patient.
About Cataract & Lens-Related Conditions
Cataracts are the leading cause of blindness worldwide. Other lens-related conditions, such as lens dislocation or complications following lens surgery, are less common but can also lead to significant vision loss when not properly managed. A cataract is a clouding or opacification of the eye’s naturally clear lens or its surrounding capsule, which prevents light from properly passing through the lens to the retina of the eye. This clouding of the lens typically caused by a gradual breakdown and aggregation of proteins in the lens over time can lead to a range of visual symptoms, including blurred vision, glare, difficulty with night driving, reduced visual acuity, halos around lights and increased light sensitivity (photophobia). While age-related cataract are the most common form, other types include congenital cataract (present at birth), traumatic cataract (resulting from injury) and secondary cataract associated with systemic diseases, certain medications or chronic anterior uveitis (eye inflammation).
In addition to cataract, lens-related conditions can involve lens dislocation (ectopia lentis), lens instability from zonular weakness or complications related to intraocular lenses after cataract surgery. Accurate diagnosis and timely, multidisciplinary management are essential to preserve vision and prevent long-term complications. Treatment may include careful monitoring, prescription of corrective lenses or medical management in the early stages, and surgical intervention when cataract significantly interfere with daily activities or quality of life.